ABI Research’s April 17 Webinar Explores Top Trends & Takeaways from Hannover Messe, ProMat, and Automate 2019 Conferences
Webinar: The Top Trends & Takeaways from 3 Industrial Conferences: Hannover Messe, ProMat, & Automate
Date: April 17, 2019 (Wednesday)
Time: 10:30 a.m. U.S. EDT
Length of Webinar: 45 minutes, plus 15-minute question-and-answer session
Hannover Messe 2019 in Germany expects to have more than 6,500 exhibitors and 220,000 visitors. ProMat forecasts 1,000 exhibitors and visitors from 115 countries while Automate anticipates 450 exhibitors; these two co-located conferences will be held in Chicago.
Expectations are immensely high from these three top industrial conferences in terms of technological innovations, especially when the manufacturing landscape is undergoing a sea change of digital transformations.
The industrial landscape is rapidly changing because of global competition, lack of energy, an insufficient labor pool, a convoluted supply chain and global sourcing environment, as well as high amounts of customization put pressure on tooling and reconfiguration. Furthermore, batch runs are getting smaller, thereby manufacturers are getting less lift out of every order.
This webinar from ABI Research will explore the aforementioned issues and identify what the most compelling technological developments were at all three conferences and how they should be maximized.
Our analysts will also give an overview of the must-have technologies needed for a “lights-out” production line on the factory floor. Technologies such as additive manufacturing, IIoT, edge and cloud computing, machine learning and artificial intelligence, advanced robotics, augmented reality, production simulation and wireless connectivity all will continue to impact manufacturing, automate it and augment the work and abilities of humans on the shop floor.
Our analysts will also answer these questions:
- What technology trends were on fire at all three conferences and why?
- What companies should you explore and why?
- What companies and technologies did not meet expectations?
- What pitfalls should be avoided when implementing digital transformations?
- What are best practices to follow when implementing digital transformations?
Below are recent research deliverables from ABI Research’s Industrial Solution, which help manufacturers digitize operations to create better quality products at lower costs:
- Generative Design Total Lifetime Value Calculator – this total lifetime value report provides a comprehensive analysis of implementation strategies and innovation, coupled with payback period analysis and total lifetime value analysis to offer unparalleled insight into the appropriate deployment strategy of generative design.
- Additive Manufacturing in Industrial Applications – this application analysis report examines what ABI Research considers to be the most significant trends and developments related to Additive Manufacturing.
- Digital Factory Data – this market data report forecasts how the growth in data will drive revenues not only for connectivity and network services but for Smart Manufacturing platforms, analytics, professional services, and security services.
- Mobile Robots: Autonomy Solution Providers – this application analysis report ABI Research provides analysis and competitive assessment of Autonomy Solution Providers (ASPs), who have managed to drive robotics adoption beyond traditional environments.
- Generative Design Vendors Competitive Assessment – this competitive assessment ranked 9 major vendors of the technology: ANSYS, Altair, Autodesk, Dassault Systèmes, GRM Consulting, ParaMatters, PTC, nTopology, and Siemens, based on ABI Research's proven unbiased innovation/implementation criteria framework.
About ABI Research
ABI Research provides strategic guidance for visionaries needing market foresight on the most compelling transformative technologies, which reshape workforces, identify holes in a market, create new business models and drive new revenue streams. ABI’s own research visionaries take stances early on those technologies, publishing groundbreaking studies often years ahead of other technology advisory firms. ABI analysts deliver their conclusions and recommendations in easily and quickly absorbed formats to ensure proper context. Our analysts strategically guide visionaries to take action now and inspire their business to realize a bigger picture. For more information about subscribing to ABI’s Research Services as well as Industrial and Custom Solutions, visionaries can contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific or visit www.abiresearch.com.
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NetMedia Group takes over the management of financial platform Investing.com's European advertising space23.7.2019 08:07:00 CEST | Press release
NetMedia Group, media B2B leader in Europe in the world of business information, and Investing.com, second largest financial services and information platform in Europe, are to form a partnership, with NetMedia Group handling the sales of advertising space for Investing.com. With average traffic of over 21 million unique users totaling over 175 million sessions in 31 countries, Investing.com is one of the top three global financial websites and has the most downloaded financial management app. For Investing.com, the aim of the new partnership is to maximize digital advertising revenue through the NetMedia Group's European teams. NetMedia Group's goal is to expand its advertising services by offering a new vertical market for finance, in order to boost the range of services it has available to decision-makers for upper socio-professional target groups. About NetMedia Group: NetMedia Group is a B2B media group located in five countries across Europe; it employs nearly 150 staff members a
Frost & Sullivan Names Luminati the 2019 Global Market Leader in the Enterprise IP Proxy Networks Market23.7.2019 08:00:00 CEST | Press release
Luminati, the Israeli company that allows businesses to experience the web through the eyes of individual consumers throughout the world, today announced it has received a Market Leadership Award in the first independent analysis of the sector. Luminati’s enterprise IP proxy network (IPPN) services for global retailers, brand owners and advertising networks feature strongly in the report by analyst firm Frost & Sullivan. The report outlines a relatively new, but rapidly growing market and recognizes Luminati’s leading position in the provision of solutions that are increasingly important for businesses to remain competitive and compliant in the digital landscape. [S1] “The market for enterprise IP proxy network solutions is in its early growth stages, basically being invented by Luminati only a few years ago. With the more specialized targeting of customers by demographics and location, companies are finding it more difficult than ever to do competitive analysis and verify advertising,
LifeSpan BioSciences Releases Best-In-Class PathPlus™ Top Performing Immunohistochemistry Antibodies for Cancer Targets23.7.2019 08:00:00 CEST | Press release
LifeSpan BioSciences, Inc. (LSBio™), the industry leader in molecular pathology, today announced the first release of its PathPlus™ series of antibodies. These 565 antibodies were selected from among thousands tested and identified to be the best performing reagents for immunohistochemical detection of 200 high-value cancer targets in formalin-fixed paraffin-embedded human tissues. Antibody validation has become an industry roadblock as thousands of antibodies have become available to customers who face difficult choices in determining which antibodies are the best performers for each application, including immunohistochemistry, flow cytometry, ELISA, Western blot, or immunofluorescence. Antibodies that perform well in one assay, such as IHC, may not be the most specific reagent for another assay, such as flow cytometry. “Identifying the optimal reagents to use in their experiments is a pain point for researchers,” said LSBio CEO Heather Holemon. “There is a tremendous need to identify
IDEMIA Will Present Its H1 2019 Financial Results to Investors on July 30, 201923.7.2019 07:00:00 CEST | Press release
IDEMIA, the world leader in Augmented Identity, today announced that it will present its H1 2019 financial results to investors on Tuesday July 30, 2019. Yann Delabrière (CEO) and Laurent Lemaire (CFO) will be presenting the financial results and taking questions the same day at 3:30 pm CET (2:30 pm London Time / 9:30 am New York Time). For more information, please refer to our website: https://investors.idemia.com/ About IDEMIA IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel), in the physical as well as digital space. Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our identity – whet
Gain Therapeutics SA Announces Award Notification of a €1.4M Grant Support From Eurostars-2 Together With the Institute for Research in Biomedicine and Neuro-Sys SAS After Having Scored 2nd Among 325 Eligible Applications23.7.2019 06:30:00 CEST | Press release
Gain Therapeutics SA, a biotechnology company discovering and developing novel therapeutics to target lysosomal enzymes involved in inborn errors of metabolism and in central nervous system (CNS) diseases, today announced that together with Dr. Maurizio Molinari from the Institute for Research in Biomedicine, Bellinzona (Switzerland) affiliated to the Università della Svizzera italiana (USI) and Neuro-Sys SAS in Gardanne (France), it has received funding support from Eurostars-2 joint programme with co-funding from the European Union Horizon 2020 research and Innosuisse – Swiss Innovation Agency. This grant will further strengthen Gain Therapeutics’s novel therapeutic approach for targeting rare diseases in the CNS, where lysosomal misfolded enzymes lead to sever clinical phenotypes, where no treatment is available and/or high unmet medical needs still do afflict patients, families and carers. This funding will support the development of the drugs portfolio of Gain Therapeutics for the
iBASIS Accelerates Growth With JC Geha as Chief Operating Officer23.7.2019 06:00:00 CEST | Press release
iBASIS, provider of communications solutions for operators and digital players worldwide, today announced the appointment of JC Geha as its COO. He will take his new post effective August 1, and be based at iBASIS’ headquarters in Lexington, Massachusetts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190722005757/en/ JC Geha (Photo: Business Wire) Formerly Senior Vice President, Head of International Technology and Services for Deutsche Telekom, and of Managed Services for Ericsson, Geha brings to iBASIS an impressive track record of profitable growth, technology and digital transformation expertise. His expertise spans 25 years of deep global industry relationships across the United States, Europe, Middle East, and Africa. Geha will lead iBASIS’ global operations, engineering, IT, and product development. He will report to iBASIS’ CEO and founder of the Group Tofane Global, Alexandre Pébereau, with the responsibility of g